SCM
ZVRA icon

Sterling Capital Management’s Zevra Therapeutics ZVRA Stock Holding History

Sterling Capital Management’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.37K Sell
361
-5
-1% -$45 ﹤0.01% 2864
2025
Q4 		$3.28K Buy
366
+235
+179% +$2.22K ﹤0.01% 2991
2025
Q3 		$1.25K Hold
131
– – ﹤0.01% 3049
2025
Q2 		$1.15K Sell
131
-358
-73% -$2.9K ﹤0.01% 3039
2025
Q1 		$3.66K Sell
489
-208
-30% -$1.65K ﹤0.01% 2314
2024
Q4 		$5.81K Buy
697
+611
+710% +$5.21K ﹤0.01% 2394
2024
Q3 		$597 Buy
+86
New +$584 ﹤0.01% 2786

Other funds holding ZVRA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return